-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Horizon Therapeutics Public Ltd Co quarterly/annual Amortization of Intangible Assets history and growth rate from 2011 to 2022.
- Horizon Therapeutics Public Ltd Co Amortization of Intangible Assets for the quarter ending June 30, 2023 was $89.6M, a 1.86% decline year-over-year.
- Horizon Therapeutics Public Ltd Co Amortization of Intangible Assets for the twelve months ending June 30, 2023 was $364M, a 0.58% increase year-over-year.
- Horizon Therapeutics Public Ltd Co annual Amortization of Intangible Assets for 2022 was $367M, a 8.98% increase from 2021.
- Horizon Therapeutics Public Ltd Co annual Amortization of Intangible Assets for 2021 was $336M, a 31.8% increase from 2020.
- Horizon Therapeutics Public Ltd Co annual Amortization of Intangible Assets for 2020 was $255M, a 10.7% increase from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)